Cory Randall Ellspermann

CIK: 0002082083

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (54.5%)

Compensation grants

Other (G, F, J, C, D, …)5 (45.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

INMB

Inmune Bio, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (11 total)

INMB
Inmune Bio, Inc.
Dec 1, 2025
Award(A)
Option (right to buy)
Direct
300K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Disposition(D)
Stock Option (right to buy)
Direct
75K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Award(A)
Stock Option (right to buy)
Direct
75K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Disposition(D)
Stock Option (right to buy)
Direct
40K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Award(A)
Stock Option (right to buy)
Direct
40K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Disposition(D)
Stock Option (right to buy)
Direct
30K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Award(A)
Stock Option (right to buy)
Direct
30K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Disposition(D)
Stock Option (right to buy)
Direct
70K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Award(A)
Stock Option (right to buy)
Direct
70K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Disposition(D)
Stock Option (right to buy)
Direct
30K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Award(A)
Stock Option (right to buy)
Direct
30K shares-

		Type	Shares	Price		Ownership
Dec 1, 2025	INMB Inmune Bio, Inc.	Award(A) Option (right to buy)	300,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Disposition(D) Stock Option (right to buy)	75,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Award(A) Stock Option (right to buy)	75,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Disposition(D) Stock Option (right to buy)	40,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Award(A) Stock Option (right to buy)	40,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Disposition(D) Stock Option (right to buy)	30,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Award(A) Stock Option (right to buy)	30,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Disposition(D) Stock Option (right to buy)	70,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Award(A) Stock Option (right to buy)	70,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Disposition(D) Stock Option (right to buy)	30,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Award(A) Stock Option (right to buy)	30,000	-	-	Direct

1-11 of 11 transactions

About Ellspermann Cory Randall

Ellspermann Cory Randall (SEC CIK 0002082083) files insider reports with the SEC as Interim CFO of Inmune Bio, Inc. (INMB).

Signal8 holds 3 ownership filings by Ellspermann Cory Randall (1 Form 3, 2 Form 4), filed between Aug 18, 2025 and Dec 2, 2025. Those filings report 11 transactions, from Nov 18, 2025 to Dec 1, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Ellspermann Cory Randall's filings is in BOCA RATON, FL.

Recent filings by Ellspermann Cory Randall

Dec 1, 2025: Grant or award of INMB derivative securities (Form 4, code A).
Nov 18, 2025: Disposition to issuer transaction of INMB derivative securities (Form 4, code D).
Nov 18, 2025: Grant or award of INMB derivative securities (Form 4, code A).
Nov 18, 2025: Disposition to issuer transaction of INMB derivative securities (Form 4, code D).
Nov 18, 2025: Grant or award of INMB derivative securities (Form 4, code A).

Other insiders filing for Inmune Bio, Inc. (INMB)

Clark Ronnie Duane, Director
SAPIRSTEIN JAMES, Director
Juda Scott, Director
Lowdell Mark William, Chief Scientific Officer
Moss David J, Chief Executive Officer
Schroeder Timothy j, Director

How to read Form 4 transaction codes